Rational application of antihypertensive calcium channel blockers in renal diseases

Weiming Wang,Lili Xu
DOI: https://doi.org/10.3877/cma.j.issn.2095-3216.2014.05.006
2014-01-01
Abstract:The incidence of hypertension is high in the Chinese population.And the first cause of secondary hypertension is chronic kidney disease (CKD).To control the hypertension in CKD patients, angiotensin converting enzyme inhibitor (ACEI)or angiotensin receptor blocker (ARB)is the first choice. However,as single drug use of ACEI or ARB does not have satisfactory effect in controlling the hypertension of CKD patients,combination of other antihypertensive drugs is usually needed.Calcium channel blockers (CCB)are first-line antihypertensive drugs,but were less used in CKD patients previously due to their adverse effects.With the research progress and the development of new preparations,CCB have their certain places and advantages in treatment of hypertension patients with CKD.Rational application of CCB can improve prognosis of the kidney so as to benefit the patients.
What problem does this paper attempt to address?